LOADING

Type to search

Tag: 3b4

Eczema Expo 2024: A Treat for All - National Eczema Association
Eczema News
Deucravacitinib Shows Significant Efficacy and Safety in Phase 3b/4 Trial for Moderate to Severe Scalp Psoriasis – Dermatology Times
eczemarelief October 28, 2024

Deucravacitinib Shows Significant Efficacy and Safety in Phase 3b/4 Trial for Moderate to Severe Scalp Psoriasis  Dermatology Times Source link

chat_bubble0 Comment visibility157 Views
Eczema-Relief.com ©All rights reserved.